Edinburgh Research Explorer

Drug firms face fines for lack of antibiotic action

Press/Media: Expert Comment

Description

Pharmaceutical companies that are not researching new antibiotics should face fines if the industry fails to agree a deal with the government within six months, a leading government adviser on superbugs has said.

Period26 Jan 2019

Pharmaceutical companies that are not researching new antibiotics should face fines if the industry fails to agree a deal with the government within six months, a leading government adviser on superbugs has said.

References

TitleDrug firms face fines for lack of antibiotic action
Media name/outletThe Times
Date of coverage26/01/19

ID: 110259440